Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Chemours Co Director's Dealing 2021

Mar 3, 2021

31561_dirs_2021-03-03_f86756e0-33d0-4f85-8feb-32ec9f935a95.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2021-03-01

Reporting Person: Abbott Matthew S (VP, CAO & Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-01 Common Stock F 581 $24.01 Disposed 22117.0672 Direct
2021-03-01 Common Stock A 1249 Acquired 23366.0672 Direct
2021-03-01 Common Stock A 10412 Acquired 33778.0672 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-01 Stock Option (Right to Buy) $24.01 A 12269 Acquired 2031-03-01 Common Stock (12269) Direct

Footnotes

F1: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2022.

F3: Restricted Stock Unit (RSU) award scheduled to vest with respect to 100% of the RSUs, including dividend equivalent units, on March 1, 2024.

F4: Includes directly owned shares, restricted stock units and dividend equivalent units.

F5: These options are scheduled to vest in three equal annual installments beginning on March 1, 2022.